Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients
The DOI matches its Crossref record; 24 of the 26 references it cites were found in a registry or an index.
Abstract
Background CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy) is commonly overlooked or misdiagnosed owing to its recent identification and its variable mode of presentation. The defective gene in CADASIL is Notch3, which encodes a large transmembrane receptor. To set up a diagnostic test and to delineate the Notch3 domains involved in CADASIL., we undertook mutations analysis in this gene in a group of CADASIL patients.Methods 50 unrelated patients with CADASIL and 100 healthy controls were screened for mutations along the entire Notch3 sequence, by means of single-strand conformation polymorphism, heteroduplex, and sequence analysis.Findings Strongly stereotyped mis-sense mutations, located within the epidermal-growth-factor-like (EGF-like) repeats, in the extracellular domain of Notch3, were detected in 45 patients. Clustering of mutations within the two exons encoding the first five EGF-like repeats was observed (32 patients). All these mutations lead to loss or gain of a cysteine residue and therefore to an unpaired number of cysteine residues within a given EGF domain. None of these mutations was found in the 100 controls.Interpretation Because of the strong clustering and highly stereotyped nature of the pathogenetic mutations detected in CADASIL patients, and easy and reliable diagnostic test for CADASIL is feasible. The findings suggest that aberrant dimerisation of Notch3, due to abnormal disulphide bridging with another Notch3 molecule or with another protein, may be involved in the pathogenesis of this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nearly all cases of CADASIL are caused by missense mutations of the Notch3 gene that either create or eliminate cysteine residues.165”
Citations
Cites
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068
Self-citationArtavanis-Tsakonas, S., Matsuno, K., & Fortini, M. E. (1995) · Science · doi:10.1126/science.7716513 · Cited by 1,303
Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., et al. (1995) · Science · doi:10.1126/science.7824936 · Cited by 841
Rebay, I., Fleming, R. J., Fehon, R. G., Cherbas, L., Cherbas, P., & Artavanis-Tsakonas, S. (1991) · Cell · doi:10.1016/0092-8674(91)90064-6 · Cited by 772
Tournier-Lasserve, E., Joutel, A., Melki, J., Weissenbach, J., Lathrop, G. M., Chabriat, H., Mas, J.-L., Cabanis, E.-A., Baudrimont, M., Maciazek, J., et al. (1993) · Nature Genetics · doi:10.1038/ng0393-256 · Cited by 682
Self-citationClinical spectrum of CADASIL: a study of 7 families
Chabriat, H., Vahedi, K., Bousser, M. G., Iba-Zizen, M. T., Joutel, A., Nibbio, A., Nagy, T. G., Tournier Lasserve, E., Krebs, M. O., Julien, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91557-5 · Cited by 669
Self-citationRebay, I., Fehon, R. G., & Artavanis-Tsakonas, S. (1993) · Cell · doi:10.1016/0092-8674(93)90423-n · Cited by 409
Epidermal growth factor-like modules
Campbell, I. D., & Bork, P. (1993) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(05)80111-3 · Cited by 351
Ruchoux, M. M., Guerouaou, D., Vandenhaute, B., Pruvo, J.-P., Vermersch, P., & Leys, D. (1995) · Acta Neuropathologica · doi:10.1007/bf00571504 · Cited by 329
Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study.
Baudrimont, M., Dubas, F., Joutel, A., Tournier-Lasserve, E., & Bousser, M. G. (1993) · Stroke · doi:10.1161/01.str.24.1.122 · Cited by 321
Self-citation
Research works printed but not linked: 1
- Davous, 1991, Démence sous corticale familiale avec leucoencéphalopathie artériopathique: observation clinicopathologique., Rev Neurol (Paris), 5, 376
Cited by
Items 101–200 of 735
Role of Notch signaling in neurovascular aging and Alzheimer’s disease
Kapoor, A., & Nation, D. A. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.12.011 · Cited by 101
Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome
Morrissette, J. J. D., Colliton, R. P., & Spinner, N. B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.4.405 · Cited by 100
“The majority of CADASIL patients have mutations that result in gain or loss of cysteine residues within the EGF-like repeats of the Notch3 protein (28,29,46).”
BackgroundInfluentialMcCullagh, C. D., Craig, D., McIlroy, S. P., & Passmore, A. P. (2001) · Advances in Psychiatric Treatment · doi:10.1192/apt.7.1.24 · Cited by 67
“Fish consumption, an important source of Ω-3 polyunsaturated fatty acids, was inversely related to dementia, and in particular to Alzheimer's disease, in the Rotterdam incident analysis (Kalmijn et al, 1997).”
CADASIL brain vessels show a HTRA1 loss-of-function profile
Zellner, A., Scharrer, E. M., Arzberger, T., Oka, C., Domenga, V., Joutel, A., Lichtenthaler, S. F., Müller, S. A., Dichgans, M., & Haffner, C. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1853-8 · Cited by 100
Self-citationTuominen, S., Juvonen, V., Amberla, K., Jolma, T., Rinne, J. O., Tuisku, S., Kurki, T., Marttila, R., Pöyhönen, M., Savontaus, M.-L., et al. (2001) · Stroke · doi:10.1161/01.str.32.8.1767 · Cited by 87
Impaired Vascular Mechanotransduction in a Transgenic Mouse Model of CADASIL Arteriopathy
Dubroca, C., Lacombe, P., Domenga, V., Maciazek, J., Levy, B., Tournier-Lasserve, E., Joutel, A., & Henrion, D. (2005) · Stroke · doi:10.1161/01.str.0000149949.92854.45 · Cited by 98
Self-citationYield of Screening for CADASIL Mutations in Lacunar Stroke and Leukoaraiosis
Dong, Y., Hassan, A., Zhang, Z., Huber, D., Dalageorgou, C., & Markus, H. S. (2003) · Stroke · doi:10.1161/01.str.0000048162.16852.88 · Cited by 90
Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL
Mayer, M., Straube, A., Bruening, R., Uttner, I., Pongratz, D., Gasser, T., Dichgans, M., & Müller-Höcker, J. (1999) · Journal of Neurology · doi:10.1007/s004150050398 · Cited by 97
Small Vessel Disease and Subcortical Vascular Dementia
Kalaria, R. N., & Erkinjuntti, T. (2006) · Journal of Clinical Neurology · doi:10.3988/jcn.2006.2.1.1 · Cited by 88
“Notch 3 mutations consistently result in either a gain or loss of one (or more odd number of) cysteine residue(s) in one of the 34 epidermal growth factor-like repeats in the aminoterminal region of the molecule.(85) It is not entirely clear which step in the Notch signalling pathway leads to the charactersitic vascul…”
BackgroundWang, W., Campos, A. H., Prince, C. Z., Mou, Y., & Pollman, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201409200 · Cited by 97
Low, W. C., Junna, M., Borjesson-Hanson, A., Morris, C. M., Moss, T. H., Stevens, D. L., St Clair, D., Mizuno, T., Zhang, W. W., Mykkanen, K., et al. (2007) · Brain · doi:10.1093/brain/awl360 · Cited by 73
Lee, Y., Liu, C.-S., Chang, M.-H., Lin, K., Fuh, J., Lu, Y.-C., Liu, Y., & Soong, B. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0091-3 · Cited by 94
“In Caucasians, NOTCH3 mutations were initially demonstrated to cluster in exons 2 to 6, with the highest frequency in exon 4 [6, 8].”
BackgroundNotch3 in Development, Health and Disease
Hosseini-Alghaderi, S., & Baron, M. (2020) · Biomolecules · doi:10.3390/biom10030485 · Cited by 93
“Most CADASIL mutations either substitute or introduce a cysteine within Notch3 EGF modules, potentially destabilising the disulphide bonding pattern and module fold [74].”
BackgroundRutten, J. W., Van Eijsden, B. J., Duering, M., Jouvent, E., Opherk, C., Pantoni, L., Federico, A., Dichgans, M., Markus, H. S., Chabriat, H., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0306-z · Cited by 91
Self-citationCADASIL: new advances in basic science and clinical perspectives
Ferrante, E. A., Cudrici, C. D., & Boehm, M. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000497 · Cited by 90
The Siblings With Ischemic Stroke Study (SWISS) Protocol
Meschia, J. F., Brown, R. D., Brott, T. G., Chukwudelunzu, F. E., Hardy, J., & Rich, S. S. (2002) · BMC Medical Genetics · doi:10.1186/1471-2350-3-1 · Cited by 90
Santa, Y., Uyama, E., Chui, D. H., Arima, M., Kotorii, S., Takahashi, K., & Tabira, T. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00109-6 · Cited by 90
Splice site mutation causing a seven amino acid Notch3 in-frame deletion in CADASIL
Joutel, A., Chabriat, H., Vahedi, K., Domenga, V., Vayssière, C., Ruchoux, M., Lucas, C., Leys, D., Bousser, M., & Tournier‐Lasserve, E. (2000) · Neurology · doi:10.1212/wnl.54.9.1874 · Cited by 90
Self-citationStroke Genomics: Approaches to Identify, Validate, and Understand Ischemic Stroke Gene Expression
Read, S., Parsons, A. A., Harrison, D. C., Philpott, K. L., Kabnick, K. S., O'Brien, S., Clark, S. M., Brawner, M. E., Bates, S., Gloger, I., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200107000-00001 · Cited by 90
“In CADASIL, approximately 90% of patients have missense mutations in extracellular domains of the protein product, whereas in approximately 70% of patients, the mutation is located within exons 3 and 4 (Joutel et al., 1997).”
BackgroundCADASIL: A Critical Look at a Notch Disease
Louvi, A., Arboleda‐Velásquez, J. F., & Artavanis‐Tsakonas, S. (2006) · Developmental Neuroscience · doi:10.1159/000090748 · Cited by 89
“The prevalence of CADASIL remains largely unknown and likely underestimated. However, CADASIL made it to the movies, as one of the characters in Alejandro Amenabar’s 2004 film ‘Mar adentro’ (The Sea Inside) is afflicted with this disorder. The CADASIL-linked mutations identified to date are almost exclusively single-b…”
BackgroundNotch signaling in the developing cardiovascular system
Niessen, K. S., & Karsan, A. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00415.2006 · Cited by 89
“Missense point mutations in the first five EGF repeats in the Notch3 locus resulting in an odd number of cysteine residues in the EGF repeat regions are found in 95% of CADASIL cases (16, 54, 56).”
BackgroundPescini, F., Nannucci, S., Bertaccini, B., Salvadori, E., Bianchi, S., Ragno, M., Sarti, C., Valenti, R., Zicari, E., Moretti, M., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.665927 · Cited by 77
“2871 Cerebral autosomaldominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL; MIM 125310) is an autosomaldominant smallvessel disease (SVD) caused by highly stereotyped mutations on exons 2 to 23 of the NOTCH3 gene.(1,2) The disease is characterized by migraine, frequently with aura, transie…”
BackgroundThe pathogenesis of CADASIL: an update
Kalaria, R. N., Viitanen, M. H., Kalimo, H., Dichgans, M., & Tabira, T. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.008 · Cited by 87
“A subsequent study [7] reported a characteristic Notch3 mutation pattern in 50 unrelated French CADASIL patients.”
Backgroundvan den Boom, R., Lesnik Oberstein, S. A. J., van Duinen, S. G., Bornebroek, M., Ferrari, M. D., Haan, J., & van Buchem, M. A. (2002) · Radiology · doi:10.1148/radiol.2243011123 · Cited by 86
NOTCH3 mutations and clinical features in 33 mainland Chinese families with CADASIL
Wang, Z., Yuan, Y., Zhang, W., Lv, H., Hong, D., Chen, B., Liu, Y., Luan, X., Xie, S., & Wu, S. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.209247 · Cited by 82
“Our results are quite different from those of Taiwanese patients, but are in agreement with the Caucasian population.(9) These data support the finding that the spectrum of NOTCH3 mutation is different not only from country to country, but also from region to region in the same population.”
ResultDiagnostic Notch3 sequence analysis in CADASIL: Three new mutations in Dutch patients
Oberstein, S. A. J. L., Ferrari, M. D., Bakker, E., van Gestel, J., Kneppers, A. L. J., Frants, R. R., Breuning, M. H., & Haan, J. (1999) · Neurology · doi:10.1212/wnl.52.9.1913 · Cited by 80
Wallays, G., Nuyens, D., Silasi‐Mansat, R., Souffreau, J., Callaerts‐Vegh, Z., Nuffelen, A. V., Moons, L., D’Hooge, R., Lupu, F., Carmeliet, P., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.237859 · Cited by 85
CADASIL and migraine: A narrative review
Liem, M. K., Oberstein, S. A. J. L., van der Grond, J., Ferrari, M. D., & Haan, J. (2010) · Cephalalgia · doi:10.1177/0333102410370870 · Cited by 86
“It is caused by mutations in the NOTCH3 gene located on chromosome 19 (10).”
BackgroundCADASIL in central Italy: a retrospective clinical and genetic study in 229 patients
Bianchi, S., Zicari, E., Carluccio, A., Donato, I. D., Pescini, F., Nannucci, S., Valenti, R., Ragno, M., Inzitari, D., Pantoni, L., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7533-2 · Cited by 85
“Irrespective to their type, pathogenetic NOTCH3 mutations lead to an odd number of cysteine residues within the EGF-like domain [8].”
BackgroundThe spectrum of Notch3 mutations in 28 Italian CADASIL families
Dotti, M. T. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.048207 · Cited by 78
William M. Feinberg Lecture: Stroke Therapy in the Year 2025
Broderick, J. P. (2003) · Stroke · doi:10.1161/01.str.0000106160.34316.19 · Cited by 86
C455Rnotch3mutation in a Colombian CADASIL kindred with early onset of stroke
Arboleda‐Velásquez, J. F., Lopera, F. J., López, E., Frosch, M. P., Falla, D. S., Gutierrez, J. E., Vargas, S. A., Medina, M., de Arrieta, C. M., Lebo, R. V., et al. (2002) · Neurology · doi:10.1212/wnl.59.2.277 · Cited by 83
Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3 -negative patients
Pantoni, L., Pescini, F., Nannucci, S., Sarti, C., Bianchi, S., Dotti, M. T., Federico, A., & Inzitari, D. (2010) · Neurology · doi:10.1212/wnl.0b013e3181c7da7c · Cited by 82
Diffusion tensor imaging study of subcortical gray matter in CADASIL
Molko, N., Pappata, S., Mangin, J. F., Poupon, C., Vahedi, K., Jobert, A., LeBihan, D., Bousser, M. G., & Chabriat, H. (2001) · Stroke · doi:10.1161/hs0901.094255 · Cited by 82
Self-citationWang, M. M. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00047-8 · Cited by 83
Heritability of MRI Lesion Volume in CADASIL: Evidence for Genetic Modifiers
Opherk, C., Peters, N., Holtmannspötter, M., Gschwendtner, A., Müller-Myhsok, B., & Dichgans, M. (2006) · Stroke · doi:10.1161/01.str.0000245084.35575.66 · Cited by 73
Therapeutic NOTCH3 cysteine correction in CADASIL using exon skipping:in vitroproof of concept
Rutten, J. W., Dauwerse, H. G., Peters, D. J. M., Goldfarb, A., Venselaar, H., Haffner, C., van Ommen, G. B., Aartsma-Rus, A. M., & Oberstein, S. A. J. L. (2016) · Brain · doi:10.1093/brain/aww011 · Cited by 79
“Arterioscler Thromb Vasc Biol 2015 February;35(2):409-20.”
BackgroundInfluentialEvaluation of diagnostic NOTCH3 immunostaining in CADASIL
Oberstein, S. A. J. L., van Duinen, S. G., van den Boom, R., Maat–Schieman, M. L. C., van Buchem, M. A., van Houwelingen, H. C., Hegeman-Kleinn, I. M., Ferrari, M. D., Breuning, M. H., & Haan, J. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0701-6 · Cited by 79
“dard [7], or electron microscopic examination of a skin biopsy revealing GOM in the vasculature [13], is requiSaskia A.”
BackgroundTakahashi, K., Adachi, K., Yoshizaki, K., Kunimoto, S., Kalaria, R. N., & Watanabe, A. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp468 · Cited by 62
“Therefore, the formation of abnormal disulfide bridges has been thought to affect receptor trafficking, processing, specificity for ligand binding and/or signal transduction (10).”
BackgroundHeritable and non-heritable uncommon causes of stroke
Bersano, A., Kraemer, M., Burlina, A. P., Mancuso, M., Finsterer, J., Sacco, S., Salvarani, C., Caputi, L., Chabriat, H., Oberstein, S. A. J. L., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09836-x · Cited by 77
Self-citationCerebral small vessel diseases: cerebral microangiopathies
Ringelstein, E. B., & Nabavi, D. G. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000162861.26971.03 · Cited by 69
Lesnik Oberstein, S. A. J., Jukema, J. W., van Duinen, S. G., Macfarlane, P. W., van Houwelingen, H. C., Breuning, M. H., Ferrari, M. D., & Haan, J. (2003) · Medicine · doi:10.1097/01.md.0000085054.63483.40 · Cited by 66
“C autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL; OMIM 1253101) is a hereditary disease caused by stereotypic mutations in the NOTCH3 gene (OMIM 600276) (12).”
BackgroundImplication of APP Secretases in Notch Signaling
Hartmann, D., Tournoy, J., Säftig, P., Annaert, W. G., & Strooper, B. D. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:171 · Cited by 76
“These mutations cause a dominant inhibition of notch func- Journal of Molecular Neuroscience Volume 17, 2001 tion probably because of clustering of Notch receptors via the unpaired cysteins (Joutel et al., 1997, 2000; Fryxell et al., 2001).”
BackgroundChoi, J. C. (2010) · Journal of Clinical Neurology · doi:10.3988/jcn.2010.6.1.1 · Cited by 72
CADASIL: Experimental Insights From Animal Models
Ayata, C. (2010) · Stroke · doi:10.1161/strokeaha.110.595207 · Cited by 75
Notch signaling as a therapeutic target
Nam, Y., Aster, J. C., & Blacklow, S. C. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00346-0 · Cited by 75
Chromosomal duplication of band 10p14 segregating through four generations
Voullaire, L. E., GARDNER, R. J. M., VAUX, C., ROBERTSON, A., OERTEL, R., & SLATER, H. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.3.233 · Cited by 74
Physiology and pathology of notch signalling system
Bianchi, S., Dotti, M. T., & Federico, A. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20542 · Cited by 76
“…all these mutations are evident in the extracellular part of the protein, inside the EGF-repeats and invariably involved a cysteine, suggested to Joutel et al. (1997) that they could have functional consequences on receptor activity, including misfolding, abnormal dimerisation and impossible…”
BackgroundLocatelli, M., Padovani, A., & Pezzini, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00321 · Cited by 72
“For example, exon 3 is the second most frequent mutated exon in France, Germany, and England, as oppose to exon 11 in Dutch population (Joutel et al., 1997; Joutel et al., 2000; Markus et al., 2001; Peters et al., 2005; Lesnik Oberstein, S. A. et al., 2003).”
BackgroundModeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells
Ling, C., Liu, Z., Song, M., Zhang, W., Wang, S., Liu, X., Ma, S., Sun, S., Fu, L., Chu, Q., et al. (2019) · Protein & Cell · doi:10.1007/s13238-019-0608-1 · Cited by 71
Hereditary Vascular Anomalies: New Insights Into Their Pathogenesis
Tille, J., & Pepper, M. S. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000137390.56554.df · Cited by 71
Hervé, D., & Chabriat, H. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383570 · Cited by 70
“In 70% of families, mutations are located within exons 3 and 4, which encode the first 5 EGF domains.(82) In general, mutations lead to an odd number of cysteine residues within a given EGFR.”
Self-citationYamamoto, Y., Liao, Y., Lee, Y., Ihara, M., & Choi, J. C. (2023) · Journal of Clinical Neurology · doi:10.3988/jcn.2023.19.1.12 · Cited by 71
CADASIL mutations impair Notch3 glycosylation by Fringe
Arboleda‐Velásquez, J. F., Rampal, R. K., Fung, E., Darland, D. C., Liu, M., Martinez, M. C., Donahue, C. P., Navarro‐Gonzalez, M. F., Libby, P., D'Amore, P. A., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi171 · Cited by 70
“60% of the reported CADASIL mutations cluster (10,31).”
BackgroundSingle gene disorders causing ischaemic stroke
Razvi, S., & Bone, I. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0048-8 · Cited by 69
“However, the common exons involved probably differ in populations in different countries and no one strategy can be applied worldwide [55, 82].”
BackgroundKelleher, J., Dickinson, A., Cain, S. A., Hu, Y., Bates, N., Harvey, A., Ren, J., Zhang, W., Moreton, F. C., Muir, K. W., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.10.004 · Cited by 69
Monogenic causes of stroke: now and the future
Tan, R. Y. Y., & Markus, H. S. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7794-4 · Cited by 69
“odd number of cysteine residues [64].”
Patel, D., Mez, J., Vardarajan, B. N., Staley, L., Chung, J., Zhang, X., Farrell, J. J., Rynkiewicz, M. J., Cannon-Albright, L. A., Teerlink, C. C., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.1350 · Cited by 66
Vascular smooth muscle cell dysfunction in neurodegeneration
Hayes, G., Pinto, J., Sparks, S., Wang, C., Suri, S., & Bulte, D. P. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1010164 · Cited by 67
NOTCH3 mutation involving three cysteine residues in a family with typical CADASIL
Dichgans, M., Herzog, J., & Gasser, T. (2001) · Neurology · doi:10.1212/wnl.57.9.1714 · Cited by 56
Notch3 Is Essential for Regulation of the Renal Vascular Tone
Boulos, N., Helle, F., Dussaule, J., Placier, S., Milliez, P., Djudjaj, S., Guerrot, D., Joutel, A., Ronco, P. M., Boffa, J., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.170746 · Cited by 66
Self-citationMishra, A., Chauhan, G., Violleau, M., Vojinović, D., Jian, X., Bis, J. C., Li, S., Saba, Y., Grenier‐Boley, B., Yang, Q., et al. (2019) · Brain · doi:10.1093/brain/awz024 · Cited by 66
Self-citationCholinergic Neuronal Deficits in CADASIL
Keverne, J. S., Low, W. C. R., Ziabreva, I., Court, J. A., Oakley, A. E., & Kalaria, R. N. (2007) · Stroke · doi:10.1161/01.str.0000251787.90695.05 · Cited by 48
Iannucci, G., Dichgans, M., Rovaris, M., Brüning, R., Gasser, T., Giacomotti, L., Yousry, T. A., & Filippi, M. (2001) · Stroke · doi:10.1161/01.str.32.3.643 · Cited by 63
Increased Notch3 Activity Mediates Pathological Changes in Structure of Cerebral Arteries
Baron‐Menguy, C., Domenga, V., Ghezali, L., Faraci, F. M., & Joutel, A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08015 · Cited by 65
Self-citationChen, S., Wang, N., Yin, X., Liu, H., Lu, C., Zheng, Q.-J., Zhao, G., Xu, Y., Wu, L., Zhang, L., et al. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12719 · Cited by 65
Exome Resequencing Identifies Potential Tumor-Suppressor Genes that Predispose to Colorectal Cancer
Smith, C. G., Naven, M., Harris, R. C., Colley, J. P., West, H. D., Li, N., Liu, Y., Adams, R., Maughan, T., Nichols, L., et al. (2013) · Human Mutation · doi:10.1002/humu.22333 · Cited by 65
“However, nonsynonymous mutations in NOTCH3 cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (Joutel et al. 1996; Joutel et al. 1997).”
BackgroundCADASIL: yesterday, today, tomorrow
Chabriat, H., Joutel, A., Tournier‐Lasserve, E., & Bousser, M. (2020) · European Journal of Neurology · doi:10.1111/ene.14293 · Cited by 63
“abnormal disulfide dimerization of the Notch3 protein would be at the origin of the disease [12].”
BackgroundSelf-citationActivating NOTCH3 mutation in a patient with small-vessel-disease of the Brain
Fouillade, C., Chabriat, H., Riant, F., Mine, M., Arnoud, M., Magy, L., Bousser, M. G., Tournier-Lasserve, E., & Joutel, A. (2008) · Human Mutation · doi:10.1002/humu.9527 · Cited by 59
Self-citationRighart, R., Duering, M., Gonik, M., Jouvent, E., Reyes, S., Hervé, D., Chabriat, H., & Dichgans, M. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.06.006 · Cited by 62
“In all subjects, the diagnosis was confirmed either by skin biopsy or genetic testing (Joutel et al., 1997; Peters et al., 2005a).”
BackgroundSelf-citationCADASIL-causing mutations do not alter Notch3 receptor processing and activation
Low, W.-C., Santa, Y., Takahashi, K., Tabira, T., & Kalaria, R. N. (2006) · NeuroReport · doi:10.1097/01.wnr.0000223394.66951.48 · Cited by 46
“All known mutations in Notch3 linked to CADASIL reside within the tandem epidermal growth factor-like (EGF) repeat region of the receptor and result in either a gain or a loss of cysteine residue thereby causing an odd number of cysteine residues [1,5].”
BackgroundCysteine-Sparing CADASIL Mutations in NOTCH3 Show Proaggregatory Properties In Vitro
Wollenweber, F. A., Hanecker, P., Bayer-Karpinska, A., Malik, R., Bäzner, H., Moreton, F. C., Muir, K. W., Müller, S., Giese, A., Opherk, C., et al. (2015) · Stroke · doi:10.1161/strokeaha.114.007472 · Cited by 61
NOTCH3 cysteine-altering variant is an important risk factor for stroke in the Taiwanese population
Lee, Y., Chung, C., Chang, M.-H., Wang, S., & Liao, Y. (2019) · Neurology · doi:10.1212/wnl.0000000000008700 · Cited by 61
“It is usually caused by a mutation in the NOTCH3 gene (OMIMMIM*600276) that results in the alternation of a cysteine residue in the 34 epidermal growth factor–like repeat (EGFR) domains of the Notch3 protein.(2,3) CADASIL has been recognized as a rare disease with a prevalence of 1.”
BackgroundThe role of notch in modeling and maintaining the vasculature
Karsan, A. (2005) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-125 · Cited by 61
“Mutations of Notch3 in CADASIL characteristically lead to an EGF repeat domain with an odd number of cysteine residues through gain or loss of a residue (Joutel and TournierLasserve 1998; Joutel et al. 1997).”
BackgroundCADASIL Notch3 Mutant Proteins Localize to the Cell Surface and Bind Ligand
Haritunians, T., Boulter, J., Hicks, C. D., Buhrman, J., diSibio, G., Shawber, C. J., Weinmaster, G., Nofziger, D., & Schanen, C. (2002) · Circulation Research · doi:10.1161/01.res.0000013796.73742.c8 · Cited by 61
Hack, R. J., Gravesteijn, G., Cerfontaine, M. N., Santcroos, M. A., Gatti, L., Kopczak, A., Bersano, A., Duering, M., Rutten, J. W., & Lesnik Oberstein, S. A. J. (2023) · Brain · doi:10.1093/brain/awac486 · Cited by 60
“The p.Arg544Cys variant, which is predicted to be between EGFr domains 13 and 14, and the p.Arg886Cys variant, which is predicted to be between EGFr domains 22 and 23, were classified as being located in EGFr domains 13.5 and 22.5, respectively.”
InfluentialNeuropsychiatric manifestations in CADASIL
Chabriat, H., & Bousser, M. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.2/hchabriat · Cited by 59
Self-citationDetection of the founder effect in Finnish CADASIL families
Mykkänen, K., Savontaus, M., Juvonen, V., Sistonen, P., Tuisku, S., Tuominen, S., Penttinen, M. T., Lundkvist, J., Viitanen, M. H., Kalimo, H., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201221 · Cited by 59
Advances in molecular genetics and pathology of cerebrovascular disorders
Kalaria, R. N. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01836-1 · Cited by 59
Notch3 activation modulates cell growth behaviour and cross-talk to Wnt/TCF signalling pathway
Wang, T., Holt, C. M., Xu, C., Ridley, C. E., Jones, R., Baron, M., & Trump, D. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.07.019 · Cited by 58
Prakash, N., Hansson, E. M., Betsholtz, C., Mitsiadis, T. A., & Lendahl, U. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5544 · Cited by 58
“All known CADASIL mutations generate EGF-repeats with an odd number of cysteine residues, presumably leading to an unpaired cysteine residue in the extracellular domain of the mutated receptor [13].”
BackgroundO'Sullivan, M. J., Rich, P. M., Barrick, T. R., Clark, C. A., & Markus, H. S. (2003) · American Journal of Neuroradiology · Cited by 58
Mortier, G. R., Nuytinck, L., Craen, M., RENARD, J.-P., LEROY, J. G., & PAEPE, A. D. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.3.220 · Cited by 57
Evaluation of DHPLC analysis in mutational scanning of Notch3, a gene with a high G-C content
Escary, J.-L., C�cillon, M., Maciazek, J., Lathrop, M. G., Tournier‐Lasserve, E., & Joutel, A. (2000) · Human Mutation · doi:10.1002/1098-1004(200012)16:6<518::aid-humu9>3.0.co;2-q · Cited by 57
Self-citationHereditary Cerebral Small Vessel Diseases and Stroke: A Guide for Diagnosis and Management
Guey, S., Oberstein, S. A. J. L., Tournier‐Lasserve, E., & Chabriat, H. (2021) · Stroke · doi:10.1161/strokeaha.121.032620 · Cited by 56
Self-citationDistribution pattern of Notch3 mutations suggests a gain-of-function mechanism for CADASIL
Donahue, C. P., & Kosik, K. S. (2003) · Genomics · doi:10.1016/s0888-7543(03)00206-4 · Cited by 56
Genotype–phenotype correlations and effect of mutation location in Japanese CADASIL patients
Mukai, M., Mizuta, I., Watanabe-Hosomi, A., Koizumi, T., Matsuura, J., Hamano, A., Tomimoto, H., & Mizuno, T. (2020) · Journal of Human Genetics · doi:10.1038/s10038-020-0751-9 · Cited by 55
Generation of co‐dominant PCR‐based markers by duplex analysis on high resolution gels
Hauser, M., Adhami, F., Dorner, M., Fuchs, E., & Glössl, J. (1998) · The Plant Journal · doi:10.1046/j.1365-313x.1998.00271.x · Cited by 55
Functional analysis of a recurrent missense mutation in Notch3 in CADASIL
Haritunians, T. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.051854 · Cited by 49
Kim, Y.-E., Yoon, C. W., Seo, S. W., Ki, C., Kim, Y. B., Kim, J., Bang, O. Y., Lee, K. H., Kim, G., Chung, C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.004 · Cited by 53
“More than 60% of NOTCH3 mutations clustered in exons 2e6, with the highest frequency in exon 4 (Joutel et al., 1997; Markus et al., 2002; Oberstein, 2003; Peters et al., 2005).”
InfluentialProteome Analysis of Cultivated Vascular Smooth Muscle Cells from a CADASIL Patient
Ihalainen, S., Soliymani, R., Iivanainen, E., Mykkänen, K., Sainio, A., Pöyhönen, M., Elenius, K., Järveläinen, H., Viitanen, M., Kalimo, H., et al. (2007) · Molecular Medicine · doi:10.2119/2006-00069.ihalainen · Cited by 44
“duced cerebrovascular CO(2) reactivity in”
BackgroundInfluentialBruening, R. D., Dichgans, M., Berchtenbreiter, C., Yousry, T. A., Seelos, K., Wu, R., Mayer, M., Brix, G., & Reiser, M. F. (2001) · American Journal of Neuroradiology · Cited by 53
Robinson, W. P., Galetta, S. L., McCluskey, L. F., Forman, M. S., & Balcer, L. J. (2001) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00206-x · Cited by 53
Molecular Pathways of Frontotemporal Lobar Degeneration
Sleegers, K., Cruts, M., & Broeckhoven, C. V. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153144 · Cited by 53
Prevalence of CADASIL and Fabry Disease in a Cohort of MRI Defined Younger Onset Lacunar Stroke
Kilarski, L. L., Rutten‐Jacobs, L. C. A., Bevan, S., Baker, R. J., Hassan, A., Hughes, D. A., Markus, H. S., & Study, U. Y. L. S. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136352 · Cited by 52
“Two were novel (C1222G and C323S) while R169C and R207C have been previously described in Caucasian CADASIL patients [22, 23], whereas the R587C mutation only has been reported in a Korean CADASIL patient [24].”
BackgroundReversible coma with raised intracranial pressure: an unusual clinical manifestation of CADASIL
Feuerhake, F., Volk, B., Ostertag, C., Orszagh, M., Dichgans, M., Juengling, F. D., & Kassubek, J. (2002) · Acta Neuropathologica · doi:10.1007/s004010100439 · Cited by 52
“However, we are cautious about attributing the particular phenotype in this patient to this specific mutation, given that the mutation is fully within the expected spectrum of mutations, i.e., a missense mutation leading to an odd number of cysteine residues within the respective EGF-repeat domain [6, 10 ].”
BackgroundAltered white and gray matter metabolism in CADASIL: A proton MR spectroscopy and 1 H-MRSI study
Auer, D. P., Schirmer, T., Heidenreich, J., Herzog, J., Pütz, B., & Dichgans, M. (2001) · Neurology · doi:10.1212/wnl.56.5.635 · Cited by 52
CADASIL: Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Chabriat, H., Joutel, A., Vahedi, K., Tournier‐Lasserve, E., & Bousser, M. (2004) · Elsevier eBooks · doi:10.1016/b0-44-306600-0/50038-9 · Cited by 52
Self-citationA new de novo Notch3 mutation causing CADASIL
Coto, E., Menéndez, M., Navarro, R., García‐Castro, M., & Alvarez, V. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01337.x · Cited by 51
“Most of the mutations associated with CADASIL result in a loss or gain of a cysteine residue, and are clustered in the amino terminus of the protein [5,15,16].”
BackgroundHypomorphic NOTCH3 Alleles Do Not Cause CADASIL in Humans
Rutten, J. W., Boon, E. M. J., Liem, M. K., Dauwerse, J. G., Pont, M. J., Vollebregt, E., Maat‐Kievit, A., Ginjaar, H. B., Lakeman, P., van Duinen, S. G., et al. (2013) · Human Mutation · doi:10.1002/humu.22432 · Cited by 51
“The clinical diagnosis is confirmed by NOTCH3-sequencing analysis, with the detection of a typical cysteine-altering mutation [Joutel et al., 1997].”
Background
Metadata
- Authors
- Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssière, C., Cruaud, C., Maciazek, J., Weissenbach, J., Bousser, M.-G., Bach, J.-F., & Tournier-Lasserve, E.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Hôpital Lariboisière (FR)
- bioMérieux (France) (FR)
- Genethon (France) (FR)
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 350
- Issue
- 9090
- Pages
- 1511-1515
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2153287135
- Cited by
- 682
- References
- 26
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 22 · 2023: 21 · 2022: 27 · 2021: 16 · 2020: 30 · 2019: 20 · 2018: 28 · 2017: 16 · 2016: 12 · 2015: 18 · 2014: 19 · 2013: 21 · 2012: 21
- FWCI
- 17.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- CADASIL, Notch3, NOTCH3 mutations, EGF-like repeats, mutation clustering, diagnostic testing, cerebrovascular disease, leukoencephalopathy
- MeSH terms
- Receptor, Notch3, Cerebral Arterial Diseases, Cerebral Infarction, DNA Mutational Analysis, Epidermal Growth Factor, Genetic Testing, Genotype, Humans, Leukoencephalopathy, Progressive Multifocal, Mutation, Proto-Oncogene Proteins, Receptors, Cell Surface, Case-Control Studies, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.